APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Wearable Drug Delivery Systems

Compare research editions
View pricing & licenses

Selected research

Industry Research

Wearable Drug Delivery Systems Industry Research Report 2026

Report ID 17443007014 July 2026138 pages

Choose your research edition.

Industry ResearchWearable Drug Delivery Systems Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Drug Delivery Systems Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Wearable Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Drug Delivery Systems Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Drug Delivery Systems Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Wearable Drug Delivery Systems market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Wearable Drug Delivery Systems is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Wearable Drug Delivery Systems is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Wearable Drug Delivery Systems is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Wearable Drug Delivery Systems include Amgen, BD Medical, CeQur, Eitan Medical, Elcam Medical, Enable Injections, Gerresheimer, Insulet and Noble International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Wearable Drug Delivery Systems market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Wearable Drug Delivery Systems Market by Company

Amgen

BD Medical

CeQur

Eitan Medical

Elcam Medical

Enable Injections

Gerresheimer

Insulet

Noble International

Owen Mumford

ScPharmaceuticals

Sonceboz

Unilife Corporation

United Therapeutics

West Pharma

Ypsomed

Roche

Wearable Drug Delivery Systems Segment by Type

Electronical Drug Delivery Devices

Mechanical Drug Delivery Devices

Wearable Drug Delivery Systems Segment by Application

Home Care

Hospital

Clinic

Others

Wearable Drug Delivery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Wearable Drug Delivery Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Wearable Drug Delivery Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Wearable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Wearable Drug Delivery Systems Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Wearable Drug Delivery Systems Sales (k units) of Manufacturers (2021-2026) Table 7. Global Wearable Drug Delivery Systems Sales Market Share by Manufacturers (2021-2026) Table 8. Global Wearable Drug Delivery Systems Revenue of Manufacturers (2021-2026) Table 9. Global Wearable Drug Delivery Systems Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Wearable Drug Delivery Systems Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Wearable Drug Delivery Systems Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Wearable Drug Delivery Systems, Product Type & Application Table 14. Global Wearable Drug Delivery Systems Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Wearable Drug Delivery Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Amgen Company Information Table 19. Amgen Business Overview Table 20. Amgen Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Amgen Wearable Drug Delivery Systems Product Portfolio Table 22. Amgen Recent Developments Table 23. BD Medical Company Information Table 24. BD Medical Business Overview Table 25. BD Medical Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. BD Medical Wearable Drug Delivery Systems Product Portfolio Table 27. BD Medical Recent Developments Table 28. CeQur Company Information Table 29. CeQur Business Overview Table 30. CeQur Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. CeQur Wearable Drug Delivery Systems Product Portfolio Table 32. CeQur Recent Developments Table 33. Eitan Medical Company Information Table 34. Eitan Medical Business Overview Table 35. Eitan Medical Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Eitan Medical Wearable Drug Delivery Systems Product Portfolio Table 37. Eitan Medical Recent Developments Table 38. Elcam Medical Company Information Table 39. Elcam Medical Business Overview Table 40. Elcam Medical Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Elcam Medical Wearable Drug Delivery Systems Product Portfolio Table 42. Elcam Medical Recent Developments Table 43. Enable Injections Company Information Table 44. Enable Injections Business Overview Table 45. Enable Injections Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Enable Injections Wearable Drug Delivery Systems Product Portfolio Table 47. Enable Injections Recent Developments Table 48. Gerresheimer Company Information Table 49. Gerresheimer Business Overview Table 50. Gerresheimer Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Gerresheimer Wearable Drug Delivery Systems Product Portfolio Table 52. Gerresheimer Recent Developments Table 53. Insulet Company Information Table 54. Insulet Business Overview Table 55. Insulet Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Insulet Wearable Drug Delivery Systems Product Portfolio Table 57. Insulet Recent Developments Table 58. Noble International Company Information Table 59. Noble International Business Overview Table 60. Noble International Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Noble International Wearable Drug Delivery Systems Product Portfolio Table 62. Noble International Recent Developments Table 63. Owen Mumford Company Information Table 64. Owen Mumford Business Overview Table 65. Owen Mumford Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Owen Mumford Wearable Drug Delivery Systems Product Portfolio Table 67. Owen Mumford Recent Developments Table 68. ScPharmaceuticals Company Information Table 69. ScPharmaceuticals Business Overview Table 70. ScPharmaceuticals Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. ScPharmaceuticals Wearable Drug Delivery Systems Product Portfolio Table 72. ScPharmaceuticals Recent Developments Table 73. Sonceboz Company Information Table 74. Sonceboz Business Overview Table 75. Sonceboz Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Sonceboz Wearable Drug Delivery Systems Product Portfolio Table 77. Sonceboz Recent Developments Table 78. Unilife Corporation Company Information Table 79. Unilife Corporation Business Overview Table 80. Unilife Corporation Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Unilife Corporation Wearable Drug Delivery Systems Product Portfolio Table 82. Unilife Corporation Recent Developments Table 83. United Therapeutics Company Information Table 84. United Therapeutics Business Overview Table 85. United Therapeutics Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. United Therapeutics Wearable Drug Delivery Systems Product Portfolio Table 87. United Therapeutics Recent Developments Table 88. West Pharma Company Information Table 89. West Pharma Business Overview Table 90. West Pharma Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. West Pharma Wearable Drug Delivery Systems Product Portfolio Table 92. West Pharma Recent Developments Table 93. Ypsomed Company Information Table 94. Ypsomed Business Overview Table 95. Ypsomed Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Ypsomed Wearable Drug Delivery Systems Product Portfolio Table 97. Ypsomed Recent Developments Table 98. Roche Company Information Table 99. Roche Business Overview Table 100. Roche Wearable Drug Delivery Systems Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Roche Wearable Drug Delivery Systems Product Portfolio Table 102. Roche Recent Developments Table 103. Global Wearable Drug Delivery Systems Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Wearable Drug Delivery Systems Sales by Region (2021-2026) & (k units) Table 105. Global Wearable Drug Delivery Systems Sales Market Share by Region (2021-2026) Table 106. Global Wearable Drug Delivery Systems Sales by Region (2027-2032) & (k units) Table 107. Global Wearable Drug Delivery Systems Sales Market Share by Region (2027-2032) Table 108. Global Wearable Drug Delivery Systems Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Wearable Drug Delivery Systems Revenue Market Share by Region (2021-2026) Table 110. Global Wearable Drug Delivery Systems Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Wearable Drug Delivery Systems Revenue Market Share by Region (2027-2032) Table 112. North America Wearable Drug Delivery Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Wearable Drug Delivery Systems Sales by Country (2021-2026) & (k units) Table 114. North America Wearable Drug Delivery Systems Sales by Country (2027-2032) & (k units) Table 115. North America Wearable Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Wearable Drug Delivery Systems Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Wearable Drug Delivery Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Wearable Drug Delivery Systems Sales by Country (2021-2026) & (k units) Table 119. Europe Wearable Drug Delivery Systems Sales by Country (2027-2032) & (k units) Table 120. Europe Wearable Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Wearable Drug Delivery Systems Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Wearable Drug Delivery Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Wearable Drug Delivery Systems Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Wearable Drug Delivery Systems Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Wearable Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Wearable Drug Delivery Systems Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Wearable Drug Delivery Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Wearable Drug Delivery Systems Sales by Country (2021-2026) & (k units) Table 129. South America Wearable Drug Delivery Systems Sales by Country (2027-2032) & (k units) Table 130. South America Wearable Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Wearable Drug Delivery Systems Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Wearable Drug Delivery Systems Sales by Type (2021-2026) & (k units) Table 138. Global Wearable Drug Delivery Systems Sales by Type (2027-2032) & (k units) Table 139. Global Wearable Drug Delivery Systems Sales Market Share by Type (2021-2026) Table 140. Global Wearable Drug Delivery Systems Sales Market Share by Type (2027-2032) Table 141. Global Wearable Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Wearable Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Wearable Drug Delivery Systems Revenue Market Share by Type (2021-2026) Table 144. Global Wearable Drug Delivery Systems Revenue Market Share by Type (2027-2032) Table 145. Global Wearable Drug Delivery Systems Price by Type (2021-2026) & (USD/unit) Table 146. Global Wearable Drug Delivery Systems Price by Type (2027-2032) & (USD/unit) Table 147. Global Wearable Drug Delivery Systems Sales by Application (2021-2026) & (k units) Table 148. Global Wearable Drug Delivery Systems Sales by Application (2027-2032) & (k units) Table 149. Global Wearable Drug Delivery Systems Sales Market Share by Application (2021-2026) Table 150. Global Wearable Drug Delivery Systems Sales Market Share by Application (2027-2032) Table 151. Global Wearable Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Wearable Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Wearable Drug Delivery Systems Revenue Market Share by Application (2021-2026) Table 154. Global Wearable Drug Delivery Systems Revenue Market Share by Application (2027-2032) Table 155. Global Wearable Drug Delivery Systems Price by Application (2021-2026) & (USD/unit) Table 156. Global Wearable Drug Delivery Systems Price by Application (2027-2032) & (USD/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Wearable Drug Delivery Systems Distributors List Table 160. Wearable Drug Delivery Systems Customers List Table 161. Wearable Drug Delivery Systems Industry Trends Table 162. Wearable Drug Delivery Systems Industry Drivers Table 163. Wearable Drug Delivery Systems Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Wearable Drug Delivery Systems Product Image Figure 5. Global Wearable Drug Delivery Systems Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Wearable Drug Delivery Systems Market Size (2021-2032) & (US$ Million) Figure 7. Global Wearable Drug Delivery Systems Sales (2021-2032) & (k units) Figure 8. Global Wearable Drug Delivery Systems Average Price (USD/unit) & (2021-2032) Figure 9. Electronical Drug Delivery Devices Product Image Figure 10. Mechanical Drug Delivery Devices Product Image Figure 11. Home Care Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Others Product Image Figure 15. Global Wearable Drug Delivery Systems Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Wearable Drug Delivery Systems Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Wearable Drug Delivery Systems Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Wearable Drug Delivery Systems Sales by Region in 2025 Figure 21. Global Wearable Drug Delivery Systems Revenue by Region in 2025 Figure 22. North America Wearable Drug Delivery Systems Market Size by Country in 2025 Figure 23. North America Wearable Drug Delivery Systems Sales Market Share by Country (2021-2032) Figure 24. North America Wearable Drug Delivery Systems Revenue Market Share by Country (2021-2032) Figure 25. United States Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Wearable Drug Delivery Systems Market Size by Country in 2025 Figure 29. Europe Wearable Drug Delivery Systems Sales Market Share by Country (2021-2032) Figure 30. Europe Wearable Drug Delivery Systems Revenue Market Share by Country (2021-2032) Figure 31. Germany Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Wearable Drug Delivery Systems Market Size by Country in 2025 Figure 42. Asia Pacific Wearable Drug Delivery Systems Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Wearable Drug Delivery Systems Revenue Market Share by Country (2021-2032) Figure 44. China Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Wearable Drug Delivery Systems Market Size by Country in 2025 Figure 53. South America Wearable Drug Delivery Systems Sales Market Share by Country (2021-2032) Figure 54. South America Wearable Drug Delivery Systems Revenue Market Share by Country (2021-2032) Figure 55. Brazil Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Wearable Drug Delivery Systems Market Size by Country in 2025 Figure 59. Middle East and Africa Wearable Drug Delivery Systems Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Wearable Drug Delivery Systems Revenue Market Share by Country (2021-2032) Figure 61. Egypt Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Wearable Drug Delivery Systems Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Wearable Drug Delivery Systems Sales Market Share by Type (2021-2032) Figure 67. Global Wearable Drug Delivery Systems Revenue Market Share by Type (2021-2032) Figure 68. Global Wearable Drug Delivery Systems Price (USD/unit) by Type (2021-2032) Figure 69. Global Wearable Drug Delivery Systems Sales Market Share by Application (2021-2032) Figure 70. Global Wearable Drug Delivery Systems Revenue Market Share by Application (2021-2032) Figure 71. Global Wearable Drug Delivery Systems Price (USD/unit) by Application (2021-2032) Figure 72. Wearable Drug Delivery Systems Value Chain Figure 73. Wearable Drug Delivery Systems Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Wearable Drug Delivery Systems Industry Opportunities and Challenges

Scope & coverage.

Types
  • Electronical Drug Delivery Devices
  • Mechanical Drug Delivery Devices
Applications
  • Home Care
  • Hospital
  • Clinic
  • Others
Companies covered
  • Amgen
  • BD Medical
  • CeQur
  • Eitan Medical
  • Elcam Medical
  • Enable Injections
  • Gerresheimer
  • Insulet
  • Noble International
  • Owen Mumford
  • ScPharmaceuticals
  • Sonceboz
  • Unilife Corporation
  • United Therapeutics
  • West Pharma
  • Ypsomed
  • Roche

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Wearable Drug Delivery Systems Market Size (2021-2032)
  4. 2.2.2 Global Wearable Drug Delivery Systems Sales (2021-2032)
  5. 2.2.3 Global Wearable Drug Delivery Systems Market Average Price (2021-2032)
  6. 2.3 Wearable Drug Delivery Systems by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Electronical Drug Delivery Devices
  9. 2.3.3 Mechanical Drug Delivery Devices
  10. 2.4 Wearable Drug Delivery Systems by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Home Care
  13. 2.4.3 Hospital
  14. 2.4.4 Clinic
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Wearable Drug Delivery Systems Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Wearable Drug Delivery Systems Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Wearable Drug Delivery Systems Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Wearable Drug Delivery Systems Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Wearable Drug Delivery Systems Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Wearable Drug Delivery Systems, Product Type & Application
  8. 3.8 Global Manufacturers of Wearable Drug Delivery Systems, Established Date
  9. 3.9 Global Wearable Drug Delivery Systems Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Amgen
  2. 4.1.1 Amgen Company Information
  3. 4.1.2 Amgen Business Overview
  4. 4.1.3 Amgen Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Amgen Wearable Drug Delivery Systems Product Portfolio
  6. 4.1.5 Amgen Recent Developments
  7. 4.2 BD Medical
  8. 4.2.1 BD Medical Company Information
  9. 4.2.2 BD Medical Business Overview
  10. 4.2.3 BD Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 BD Medical Wearable Drug Delivery Systems Product Portfolio
  12. 4.2.5 BD Medical Recent Developments
  13. 4.3 CeQur
  14. 4.3.1 CeQur Company Information
  15. 4.3.2 CeQur Business Overview
  16. 4.3.3 CeQur Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CeQur Wearable Drug Delivery Systems Product Portfolio
  18. 4.3.5 CeQur Recent Developments
  19. 4.4 Eitan Medical
  20. 4.4.1 Eitan Medical Company Information
  21. 4.4.2 Eitan Medical Business Overview
  22. 4.4.3 Eitan Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Eitan Medical Wearable Drug Delivery Systems Product Portfolio
  24. 4.4.5 Eitan Medical Recent Developments
  25. 4.5 Elcam Medical
  26. 4.5.1 Elcam Medical Company Information
  27. 4.5.2 Elcam Medical Business Overview
  28. 4.5.3 Elcam Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Elcam Medical Wearable Drug Delivery Systems Product Portfolio
  30. 4.5.5 Elcam Medical Recent Developments
  31. 4.6 Enable Injections
  32. 4.6.1 Enable Injections Company Information
  33. 4.6.2 Enable Injections Business Overview
  34. 4.6.3 Enable Injections Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Enable Injections Wearable Drug Delivery Systems Product Portfolio
  36. 4.6.5 Enable Injections Recent Developments
  37. 4.7 Gerresheimer
  38. 4.7.1 Gerresheimer Company Information
  39. 4.7.2 Gerresheimer Business Overview
  40. 4.7.3 Gerresheimer Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Gerresheimer Wearable Drug Delivery Systems Product Portfolio
  42. 4.7.5 Gerresheimer Recent Developments
  43. 4.8 Insulet
  44. 4.8.1 Insulet Company Information
  45. 4.8.2 Insulet Business Overview
  46. 4.8.3 Insulet Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Insulet Wearable Drug Delivery Systems Product Portfolio
  48. 4.8.5 Insulet Recent Developments
  49. 4.9 Noble International
  50. 4.9.1 Noble International Company Information
  51. 4.9.2 Noble International Business Overview
  52. 4.9.3 Noble International Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Noble International Wearable Drug Delivery Systems Product Portfolio
  54. 4.9.5 Noble International Recent Developments
  55. 4.10 Owen Mumford
  56. 4.10.1 Owen Mumford Company Information
  57. 4.10.2 Owen Mumford Business Overview
  58. 4.10.3 Owen Mumford Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Owen Mumford Wearable Drug Delivery Systems Product Portfolio
  60. 4.10.5 Owen Mumford Recent Developments
  61. 4.11 ScPharmaceuticals
  62. 4.11.1 ScPharmaceuticals Company Information
  63. 4.11.2 ScPharmaceuticals Business Overview
  64. 4.11.3 ScPharmaceuticals Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 ScPharmaceuticals Wearable Drug Delivery Systems Product Portfolio
  66. 4.11.5 ScPharmaceuticals Recent Developments
  67. 4.12 Sonceboz
  68. 4.12.1 Sonceboz Company Information
  69. 4.12.2 Sonceboz Business Overview
  70. 4.12.3 Sonceboz Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sonceboz Wearable Drug Delivery Systems Product Portfolio
  72. 4.12.5 Sonceboz Recent Developments
  73. 4.13 Unilife Corporation
  74. 4.13.1 Unilife Corporation Company Information
  75. 4.13.2 Unilife Corporation Business Overview
  76. 4.13.3 Unilife Corporation Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Unilife Corporation Wearable Drug Delivery Systems Product Portfolio
  78. 4.13.5 Unilife Corporation Recent Developments
  79. 4.14 United Therapeutics
  80. 4.14.1 United Therapeutics Company Information
  81. 4.14.2 United Therapeutics Business Overview
  82. 4.14.3 United Therapeutics Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 United Therapeutics Wearable Drug Delivery Systems Product Portfolio
  84. 4.14.5 United Therapeutics Recent Developments
  85. 4.15 West Pharma
  86. 4.15.1 West Pharma Company Information
  87. 4.15.2 West Pharma Business Overview
  88. 4.15.3 West Pharma Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 West Pharma Wearable Drug Delivery Systems Product Portfolio
  90. 4.15.5 West Pharma Recent Developments
  91. 4.16 Ypsomed
  92. 4.16.1 Ypsomed Company Information
  93. 4.16.2 Ypsomed Business Overview
  94. 4.16.3 Ypsomed Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Ypsomed Wearable Drug Delivery Systems Product Portfolio
  96. 4.16.5 Ypsomed Recent Developments
  97. 4.17 Roche
  98. 4.17.1 Roche Company Information
  99. 4.17.2 Roche Business Overview
  100. 4.17.3 Roche Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Roche Wearable Drug Delivery Systems Product Portfolio
  102. 4.17.5 Roche Recent Developments
5 Global Wearable Drug Delivery Systems Market Scenario by Region
  1. 5.1 Global Wearable Drug Delivery Systems Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Wearable Drug Delivery Systems Sales by Region: 2021-2032
  3. 5.2.1 Global Wearable Drug Delivery Systems Sales by Region: 2021-2026
  4. 5.2.2 Global Wearable Drug Delivery Systems Sales by Region: 2027-2032
  5. 5.3 Global Wearable Drug Delivery Systems Revenue by Region: 2021-2032
  6. 5.3.1 Global Wearable Drug Delivery Systems Revenue by Region: 2021-2026
  7. 5.3.2 Global Wearable Drug Delivery Systems Revenue by Region: 2027-2032
  8. 5.4 North America Wearable Drug Delivery Systems Market Facts & Figures by Country
  9. 5.4.1 North America Wearable Drug Delivery Systems Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Wearable Drug Delivery Systems Sales by Country (2021-2032)
  11. 5.4.3 North America Wearable Drug Delivery Systems Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Wearable Drug Delivery Systems Market Facts & Figures by Country
  16. 5.5.1 Europe Wearable Drug Delivery Systems Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Wearable Drug Delivery Systems Sales by Country (2021-2032)
  18. 5.5.3 Europe Wearable Drug Delivery Systems Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Wearable Drug Delivery Systems Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Wearable Drug Delivery Systems Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Wearable Drug Delivery Systems Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Wearable Drug Delivery Systems Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Wearable Drug Delivery Systems Market Facts & Figures by Country
  41. 5.7.1 South America Wearable Drug Delivery Systems Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Wearable Drug Delivery Systems Sales by Country (2021-2032)
  43. 5.7.3 South America Wearable Drug Delivery Systems Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Wearable Drug Delivery Systems Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Wearable Drug Delivery Systems Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Wearable Drug Delivery Systems Sales by Type (2021-2032)
  2. 6.1.1 Global Wearable Drug Delivery Systems Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Wearable Drug Delivery Systems Sales Market Share by Type (2021-2032)
  4. 6.2 Global Wearable Drug Delivery Systems Revenue by Type (2021-2032)
  5. 6.2.1 Global Wearable Drug Delivery Systems Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Wearable Drug Delivery Systems Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Wearable Drug Delivery Systems Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Wearable Drug Delivery Systems Sales by Application (2021-2032)
  2. 7.1.1 Global Wearable Drug Delivery Systems Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Wearable Drug Delivery Systems Sales Market Share by Application (2021-2032)
  4. 7.2 Global Wearable Drug Delivery Systems Revenue by Application (2021-2032)
  5. 7.2.1 Global Wearable Drug Delivery Systems Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Wearable Drug Delivery Systems Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Wearable Drug Delivery Systems Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Wearable Drug Delivery Systems Value Chain Analysis
  2. 8.1.1 Wearable Drug Delivery Systems Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Wearable Drug Delivery Systems Production Mode & Process
  5. 8.2 Wearable Drug Delivery Systems Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Wearable Drug Delivery Systems Distributors
  8. 8.2.3 Wearable Drug Delivery Systems Customers
9 Global Wearable Drug Delivery Systems Analyzing Market Dynamics
  1. 9.1 Wearable Drug Delivery Systems Industry Trends
  2. 9.2 Wearable Drug Delivery Systems Industry Drivers
  3. 9.3 Wearable Drug Delivery Systems Industry Opportunities and Challenges
  4. 9.4 Wearable Drug Delivery Systems Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst